It's also noteworthy to see them taking on a lobbying role to...

It's also noteworthy to see them taking on a lobbying role to make the SAS B workable as more stakeholders are voicing concerns on its current operations:

"To further enhance our position as a market leader, we are investigating the possibility of working with approved prescribers in Australia to educate them on the key benefits of Linnea’s product offering. We also hope to work closely with the Australian government and associated industry bodies to facilitate a better process for patients to access cannabis oils as a treatment.

https://www.9news.com.au/health/201...nnabis-process-only-for-the-wealthy-lucky-few